New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE
New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE, Published online: 15 March 2019; doi:10.1038/s41429-019-0164-1
New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VREfrom The Journal of Antibiotics - Issue - nature.com science feeds https://ift.tt/2TEXRP7
via IFTTT
No comments:
Post a Comment